Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ERS dropped to $3.60. Happy to get some more. Q3 fully-taxed earnings of .14/share vs. .09/share the prior year. Q3 revenues up 15%. Should have favorable Q4 and annual comps in March. Dividend yield now approaching 4.5%.
Guy, the numbers here are incredible. Q4 revenues up 655%, Q4 net income up 671%. With a trailing P/E of 10, the stock would trade at $2.76. With an annualized P/E of 10 based on Q4 results, the stock would trade at $4. Both conservative considering the blistering growth rate...IF we can trust the numbers.
Wow!! HUGE news on CXTI. Q4 earnings of .10+/share on strong sequential growth in revenues!
Mobe, re ALHC
Not the next MDF, but I do think it has potential. Some positives include a trailing P/E of 5, low shares O/S, strong margins, five consecutive profitable quarters, and insider buying for the past 2 years. Negatives are no revenue growth, weak balance sheet, wide spread, and lack of trading. I don't think the stock has traded in 3 weeks, not even when they announced a 39% increase in Q1 net income...with earnings of .04/share vs. .03/share last year. Not bad for a stock at .85!
I've been trying to add some near the bid as I think this could be $1.50 stock with some top line growth. In the earnings PR, the CEO said they were implementing 2 new retail contracts...and that there was increased activity in their sales pipeline. Hopefully the joint venture announced earlier this month will also boost Q2 revenues.
There was an ALHC interview on CEOcast.com last week. Nothing earth-shattering, but CEO did say something about a deal with a major retail distributor that they had yet to announce the name of. Will be interested to see what company it is.
waligore, I recognized your name on the CC. I was hoping someone would break out what Q4 should look like based on the annual guidance given...and you did. Nice job!
Nice rebound on DCU the past couple weeks. Went down to the $2.20's. Now at $3.10! Wish we knew if the $350K licensing fee would be included in next month's Q2 results. If not, stock could drop back to $2.50.
ERS back to $4. Q3 fully-taxed earnings of .14/share vs. .09/share the prior year. Q3 revenues up 15%. Should have favorable Q4 and annual comps in March. Nothing flashy, just a solid company with a 4% dividend yield. They also paid a special dividend in December, which may signal that Q4 was strong.
otc, re CGNW
I'm holding some, but not a large position. Have been disappointed by this company twice before. Even IF they can repeat last quarter's numbers, it could be a rather flattish revenue and earnings comp vs. last year.
bigpike, re PHST
Just listened to the CC. Pretty much confirmed that Q4 could see a sharp dropoff in earnings. As such, I would say the stock is already at or above fair value (at least on an earnings basis). I like the sector they're in as well as the blue chip customers...plus they could get another big order at anytime. So I wouldn't be surprised if the stock kept moving up on the strength of the Q3 report, although I wouldn't hold into Q4 earnings. The balance sheet is weak, too.
valuemind, whenever I look at a stock...I try to come up with a fair value target based on many criteria (earnings, balance sheet, growth, etc). Obviously I'm a buyer if the stock appears undervalued at its current price. If I'm lucky enough to have a stock then rise to what I perceive as fair value, I will start locking in profits. I take profits relentlessly. Even though I timed CTIG well, I usually end up selling WAY too soon.
I certainly hope you wouldn't buy a stock mentioned on this or any other message board without doing your own DD. I think the most you can ask for on a board like this is some ideas on what stocks people think will go up (and hopefully why)...then it's up to you to research them. I get a lot of leads here since most of us are focused on microcaps with fundamentals. I remember the dark days of reading through hundreds of posts on Niz's board...to find one solid pick that required further study.
I'm a short-term investor. Earnings plays are my favorites. I try to anticpate what a company's numbers will look like based on what they did last quarter, the guidance, the comp from last year, etc. So I've been posting a little more recently as I think there could be some good ones coming up.
Congrats bigpike on PHST. High of $1.70 today! Should have joined you at the open, but worried about sustainability of the earnings. I can't believe they're keeping the same guidance as a few months ago...even after a blowout Q3. After crunching the numbers...Q4 revenues look like they should be almost as strong as Q3, but earnings could be more like .01-.02/share. The CC should shed some light on it.
PHST is another big earnings mover today. Looks like more people are realizing microcaps are where it's at! :)
Wow! CFK up nearly 40% now. Hope you were loaded Blast!! Wish I had bought at the open at $4.25. Guess I was overly concerned with currency conversion and seasonality issues. Glad to see a stock moving like this on good earnings...even on a lousy day for the broader markets.
run, re ETLT
I think Bob and some others have owned it in the past. There was a shady character involved with the company and I think the feeling was that it could be a scam.
Len, re DNDT
I thought the same thing, but look at checkmate's post regarding his conversation with Dennis Key.
valuemind, I have my share of stinkers, but thought I actually made a good call on CTIG. Made several posts about it over the last 2 months...when it sat in the high .30's. Thought with the large cash position and the strong Q3 results, the stock could see the .50's. When it got there, I announced I was taking profits.
Blast, re CFK
I noticed that report. Huge growth numbers. Was pretty excited at first. But when you convert from Canadian to US dollars, earnings are more like .13/share. Q4 and Q1 also the best quarters of the year by far, so can't annualize.
mike and jeff, re DNDT
I think checkmate's post may have sparked some buying. CEO saying Q4 would be the best quarter of the year is pretty darn encouraging. So much for getting more at .16!
wade, re ZONS
I've been accumulating since $4.80 a couple days ago. Would love to get some in the $3's. Earnings will be out on 2/8 so if you like it, I'd start a position and then add on weakness. ZONS earned a fully-taxed .10/share in a seasonally weak Q3. Sounds like revenues will be about 15% ahead of the $130M in last year's Q4. Depending on margins, could translate into a big number on the bottom line. If you haven't already, I'd check out the Q3 CC on Yahoo:
http://biz.yahoo.com/cc/2/48832.html
Darn, PHST.OB up to $1.50. Was going to try for some, but got cold feet. They had a fantastic earnings report, but the .05 in EPS doesn't seem sustainable at all. If you crunch the numbers on the guidance for net income being 5-10% of revenue (before preferred dividends)...you get a large sequential drop in Q4 earnings. Anyone follow this one?
Thanks checkmate! I'd be happy with Q4 earnings of .01/share on DNDT. That alone would probably cause a 50%-100% spike. Can't imagine what would happen if they came in at .02/share. Looking forward to the report as the annual earnings number should also look terrific.
Stock has been weak lately. I'll be picking up some more shares at these prices. One of the few I'm looking at with multi-bagger potential. Hopefully they can get the stock up to a more respectable level before any financing deal.
researcher, re UAHC
Had this one on my watchlist and took a good look at it before earnings. Figured they would have a solid quarter, but the comp wouldn't look that great. Suprised me a bit with earnings of .26/share. Stock should get a little pop tomorrow. But the lack of revenue growth will probably keep a lid on it. Plus, based on the guidance, it seems we're looking at revenues of $5.1M-$6.1M in Q3 and Q4 with earnings of .19-.22/share. So a couple of flattish top and bottom line comps coming up. Single digit P/E seems appropriate here.
JLN back down to $7. Q2 earnings due out next month. Earned a fully-taxed .32/share in Q1 vs. .13/share the prior year. Q1 revenues up 20%. They were bullish on Q2, which is their seasonally strongest quarter. Could post earnings of .45-.50/share vs. .33/share last year. Will likely be tempered by the fact that Q3 and Q4 are the company's seasonally slow periods. But they could still earn .80+/share for the year. Would mark the fourth year in a row of solid growth in revenues and earnings.
gilead, re JMIH
I couldn't find anything, either. I would imagine the current quarter is slightly weaker than the others since it encompasses the winter months of November, December, and January. But in the last earnings PR, the CEO said the industry was poised for growth in the coming months following the hurricanes. Plus they have that record backlog and leased the additional operating facilities in December to expand manufacturing and production capacity.
researcher, I think ZONS could post a monster Q4. The last CC is available on Yahoo...definitely worth a listen. Said October was just ok, and revenues were STILL tracking 15% ahead of last year. After the election uncertainly had passed, it seemed businesses were spending more in November and December. Plus there may have been tax incentives for companies to buy before yearend. ZONS also sells a lot of Apple stuff (iPods anyone?). Sounds like Q4 revenues could be north of $150M. Think .20/share is possible on the bottom line. Just wish they didn't have that 1-time gain in the year ago Q4.
btw...did you or anyone else look at that LMIA? Stock jumped from $2's to $8's after the reported an impressive Q3 turnaround in November. Now back in low $4's. Earned .14/share in Q3. The 1-time items seem to cancel each other out. Q3 revenues up 31%. Backlog jumped sequentially from $68.4M to $81M. Company provided some favorable 2005 guidance. Easy comps coming up. If Q4 earnings come in around .15/share, stock could see $6's again. We've probably got a couple months until that report, so may be able to get it in the $3's.
tbone, re RIMS
Solid company with 9 profitable quarters in a row. But you're right...I don't know what is going to drive revenues higher. Plus the comps are going to get a lot tougher. Considering Q3 revenues and earnings will likely be down rather sharply from last year, it's probably a good idea to take some profits in the .90's.
Added some more ZONS on dip to $4.35. This stock jumped to the $7's after announcing Q3 earnings of .10/share. That's their seasonally slowest quarter, so think they could post Q4 fully-taxed earnings of .12-.15/share vs. .05/share (before 1-time gain) last year. Numbers out in 2 weeks, stock could drift lower in the meantime.
Thanks apish for the reminder on ZONS. Earned a fully-taxed .10/share last quarter even though it was their seasonally weakest. Could be looking at Q4 earnings of .12-.15/share. They earned .05/share in the year ago Q4, but a 1-time gain boosted it to .16/share.
bucfan, re MNDO
On the balance sheet, it's broken up into cash and cash equivalents of $7,870,000 and long-term bank deposits of $47,000,000.
MNDO down in the $4.50's. Buying a little heavier now. Could drift lower, but should have a strong Q4 earnings report 2 weeks from today. Looking for Q4 earnings of .09-.10/share vs. .05/share last year. Revenues should be up about 30%. Love the balance sheet with over $2.50/share in cash.
Any thoughts on LMIA? Stock jumped to $8 in November when they announced a sharp Q3 turnaround. The 1-time items kind of balance out, so it looks like Q3 earnings were .14/share. Q3 revenues up 31%. Q4 and 2005 guidance seemed positive. Backlog was $81M vs. $55M last year, and also increased sequentially from $68.4M. They've got some easy comps coming up. If Q4 earnings come in at .12-.16/share vs. a loss last year, stock could get a nice pop from the low $4's.
Very nice news from PDGE. Looks like at the very least we're in for several quarters of huge revenue growth. If they continue to deliver on the bottom line like they did in Q3, this could be a $3+ stock by yearend IMO.
valuemind, re USOO
I like it because they earned .042/share in Q3. Revenues were up 20% and net income jumped 113%. A lot of companies in the trucking sector seem to be doing well and USOO has a couple of easy comps coming up. If they can post Q4 earnings of .05/share, stock could rise 50% from here IMO.
The balance sheet could be better, but it looks ok to me. Maybe because I remember how weak it was when I first bought back in 2001 in the .20's. Several years of solid profitability have led to a greatly improved shareholders equity. Minimal cash and high debt/equity ratios aren't uncommon among microcaps. I don't put much weight into those values since (in my experience) I haven't found them to be a hindrance to a rising stock price...but to each his own.
MNDO down in the $4.70's. Started accumulating. Should have a favorable Q4 report in a couple weeks. Hopefully Q4 earnings of .09-.10/share vs. .05/share last year. Both quarterly and annual revenues/net income should show sharp increases from last year. Excellent balance sheet with $2.50/share in cash. If management gives a bullish outlook on 2005, maybe this stock will finally get some respect.
Anyone following GMAI? More of a smallcap. They pre-announced some strong Q2 results last Friday. Q2 after-tax net income of $7.4M-$7.6M, up from $4M last year. Should translate into Q2 earnings of .26/share vs. .15/share last year. Second half of fiscal year is seasonally stronger...so could be looking at earnings of .30+/share in Q3 and Q4. Decent balance sheet with $1/share in cash. Stock has dipped to $11. Would like to get it at $10. Still might be good for a pop when actual numbers are released in a week or two.
USOO.OB CEO interviewed on CEOcast.com today. Was hoping he might say Q3 improvements would continue, but no clear guidance. Did say something about continued growth in revenues and net income and 2005. But considering Q1 and Q2 of 2004 were pretty soft, nothing to get excited about. Call was mostly a description of the business.
Also noticed a couple more small insider buys by the CEO and CFO at .95. They've each made several buys in January. Similar pattern to when they bought a few times in September at .50...a couple months before the stock doubled. Hopefully they're right again and we'll see $1.50+ by March.
Bargain sale on JMIH.OB. Down to .24? Annualized P/E of 6, trailing P/E of 10. Just doubled up.
Mobe, I have CXTI and JMIH. Put TARG on my watchlist today.
CXTI has the associated risks with any China company. Can the financials be trusted? I think they can, but am not convinced enough to make this a large holding. Q4 earnings will likely be down from the .09/share earned in Q3, but they should still put up earnings of close to .25/share for the year. Think we could see a pop on that news, so I'm buying again around .90.
JMIH looks attractive at .30. Fairly new issue, so doesn't have much of a following. Financials look pretty solid. Think it could see a pop to the .40's in the coming months.
stock peeker, I thought TARG.OB looked pretty good. Was going to try for some at $1.10, but it gapped up big and is now $1.40. Q2 fully-taxed earnings of .025/share. Tax rate seems unusually high...not sure why. Q2 revenues up 13%, Q2 net income up 254%. Balance sheet looks good with .28/share in cash. Will put it on my watchlist.
Since I missed TARG, I added some more USOO.OB instead. They had a great Q3...and based on the favorable reports I see coming out of the sector...think they could earn .05/share in Q4. Stock still around $1.
Len, re MSEV
Vancouver companies don't exactly have the best reputation. The hyperactive PR campaign looks a little suspicious. They're REALLY trying to pump the stock. In yesterday's PR, they actually discussed how well the stock did the last time similar news was released!
The financials on this one are ugly anyway. Unprofitable, minimal revenue, dilution problems, etc. So even if the company is legit, don't see the appeal.
Len, re CTIG TSTA
I didn't notice the Class B converts. Thanks to gilead for pointing it out. Even after looking at the 10K, I'm still confused as to how much dilution we're talking about. Haven't seen a deal like this before. Was trying to re-buy around .40 today. Might hold off now. Although chairman still bought over 600,000 shares last week at .38.
As for TSTA, I saw the posts on iHub. I agree that the environment should be very favorable for their business. But I'm still concerned about the lack of orders in recent months. 10Q next month should look great, but backlog could see a sizable sequential decline.